Jean-François Emile

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell–dependent antitumor effects

Christophe Borg, Magali Terme, Cédric Menard et al. · Journal of Clinical Investigation · 2004 · 287 citations · Full text

Medicine, Immunology, Oncology +17

Natural Killer Cell IFN-γ Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor–Bearing Patients

Cédric Menard, Jean‐Yves Blay, Christophe Borg et al. · Cancer Research · 2009 · 190 citations

Life Sciences, Immunology, Oncology +17

<i>KIT</i> and <i>PDGFRA</i> Mutations and the Risk of GI Stromal Tumor Recurrence

Heikki Joensuu, Piotr Rutkowski, Toshirou Nishida et al. · Journal of Clinical Oncology · 2015 · 173 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)

Debora Basile, Chloé Broudin, Jean-François Emile et al. · Annals of Oncology · 2022 · 42 citations · Full text

Medicine, Oncology, Surgery +15

[Recommendations for the management of GIST patients].

Jean‐Yves Blay, Bruno Landi, Sylvie Bonvalot et al. · PubMed · 2005 · 33 citations

Medicine, Surgery, Gastroenterology +2